Skip Navigation



NDT Advance Access published online on June 14, 2005
Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfh923
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/8/1525    most recent
gfh923v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Danpure, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Danpure, C. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Editorial Comment

Primary hyperoxaluria: from gene defects to designer drugs?

Christopher J. Danpure 1*

1 Department of Biology, University College London, London WC1E 6BT, UK

* To whom correspondence should be addressed.
Christopher J. Danpure, E-mail: c.danpure{at}ucl.ac.uk



This article has no Abstract. Keywords: alanine:glyoxylate aminotransferase; calcium oxalate kidney stones; glyoxylate/hydroxypyruvate reductase; nephrocalcinosis; primary hyperoxaluria; urolithiasis.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.